From: A multidisciplinary approach to screen the post-COVID-19 conditions
 | Patients’ characteristics | Total (n = 361) |
---|---|---|
Hospital admission | Age (years), median (IQR) | 59 (53–68) |
  < 65 years | 231 (64.0) | |
  ≥ 65 years | 130 (36.0) | |
Sex | Â | |
 Male | 256 (70.9) | |
 Female | 105 (29.1) | |
BMI (Kg/m2) (n = 353), median (IQR) | 27.8 (25.4–31.2) | |
  < 18.5 | 1 (0.3) | |
 18.50–24.99 | 78 (22.1) | |
 25–29.99 | 155 (43.9) | |
 30–39.99 | 105 (29.7) | |
 40 +  | 14 (4.0) | |
Smoking history (n = 338) |  | |
 Ever smoker | 176 (52.1) | |
 Never smoker | 162 (47.9) | |
Education (years) (n = 304), median (IQR) | 11 (8–13) | |
Comorbidities (n = 336) |  | |
 1 comorbidity | 112 (33.3) | |
 2 comorbidities | 135 (40.2) | |
  > 2 comorbidities | 66 (19.6) | |
 Hypertension | 143 (42.6) | |
 Myocardial infarction | 19 (5.7) | |
 Peripheral vascular disease | 18 (5.4) | |
 Solid tumors | 14 (4.2) | |
 Diabetes | 41 (12.2) | |
Clinical Score frailty (n = 318) |  | |
 1 | 105 (33) | |
 2 | 150 (47.2) | |
 3 | 51 (16.1) | |
 4 | 7 (2.2) | |
 5 | 3 (0.9) | |
 6 | 2 (0.6) | |
Discharge | Admitted to ICU | 128 (35.5) |
Severity scale* (n = 305) |  | |
 3 | 4 (1.3) | |
 4 | 38 (12.5) | |
 5 | 170 (55.7) | |
 6 | 93 (30.5) | |
Days of hospital stay (n = 325), median (IQR) | 20 (13–32) | |
Therapies at discharge | Â | |
 Steroids (n = 357) | 107 (30.0) | |
 Anticoagulant therapy (n = 361) | 69 (19.1) | |
 Oxygen therapy (n = 361) | 68 (18.8) | |
Follow-up visit | Days from discharge to follow-up visit, median (IQR) | 128 (100–195) |
Clinical Score frailty (n = 312) |  | |
 1 | 55 (17.6) | |
 2 | 135 (43.3) | |
 3 | 89 (28.5) | |
 4 | 22 (7.1) | |
 5 | 4 (1.3) | |
 6 | 6 (1.9) | |
 7 | 1 (0.3) |